To cite this paper use one of the standards below:
Please log in to watch the video
Log inBackground: Xia-Gibbs syndrome (XGS, OMIM#615829) is a rare autosomal dominant neurodevelopmental disorder caused by de novo heterozygous pathogenic variants in the AHDC1 gene. AHDC1 encodes a transcription factor (TF) involved in maintaining gene-specific chromatin interactions between enhancers and promotors during early development. Knockout of AHDC1 leads to global hypermethylation, affecting specially the methylation pattern of mesoderm genes. The AHDC1 interactome includes chromatin-modifying complexes, enhancer-binding proteins and zinc-finger TFs. However, many aspects of its functions remain unclear, as well as its involvement in neurodevelopment and the molecular mechanisms underlying XGS. Aim: To establish patient-derived cellular models to evaluate the effects of AHDC1 pathogenic variants on neurodevelopment and elucidate the mechanisms underlying XGS. Methodology: Peripheral blood mononuclear cells (PBMCs) from 13 diagnosed XGS patients were reprogrammed into induced pluripotent stem cells (iPSCs) through nucleofection with non-integrating plasmids encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, and a shRNA for p53 suppression. Quality control included testing for contamination (mycoplasma and STR - PCR), plasmid integration (OriP and EBNA-1 - PCR), somatic copy number variations (CNVs; array-CGH), and presence of germline AHDC1 variants (Sanger sequencing). Pluripotency was assessed by immunofluorescence, RTqPCR and three germ layer differentiation, validated by RTqPCR. Results: All 13 PBMC lines we successfully reprogrammed, generating cell lines with typical iPSC morphology and expression of OCT3/4 and NANOG. No mycoplasma contamination, plasmid integration, or somatic CNVs were detected. Germline AHDC1 variants were confirmed in all lines. By cell morphology, all lines were successfully differentiated into endoderm, mesoderm and ectoderm, although validation by RTqPCR is ongoing. Immunofluorescence for pluripotent markers and cross-contamination analysis is pending. Conclusion: We have developed and characterized iPSC lines from 13 XGS patients. These models will be used for neurodifferentiation and functional studies, in order to investigate the role of AHDC1 in neurodevelopment and the underlying molecular mechanisms of XGS.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper